These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30019421)

  • 1. Economic evaluation of smoking cessation in Ontario's regional cancer programs.
    Djalalov S; Masucci L; Isaranuwatchai W; Evans W; Peter A; Truscott R; Cameron E; Mittmann N; Rabeneck L; Chan K; Hoch JS
    Cancer Med; 2018 Sep; 7(9):4765-4772. PubMed ID: 30019421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Funding a smoking cessation program for Crohn's disease: an economic evaluation.
    Coward S; Heitman SJ; Clement F; Negron M; Panaccione R; Ghosh S; Barkema HW; Seow C; Leung YP; Kaplan GG
    Am J Gastroenterol; 2015 Mar; 110(3):368-77. PubMed ID: 25350768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.
    Guerriero C; Cairns J; Roberts I; Rodgers A; Whittaker R; Free C
    Eur J Health Econ; 2013 Oct; 14(5):789-97. PubMed ID: 22961230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits and economic advantages associated with increased utilization of a smoking cessation program.
    Datta SK; Dennis PA; Davis JM
    J Comp Eff Res; 2020 Aug; 9(11):817-828. PubMed ID: 32815740
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of extended cessation treatment for older smokers.
    Barnett PG; Wong W; Jeffers A; Munoz R; Humfleet G; Hall S
    Addiction; 2014 Feb; 109(2):314-22. PubMed ID: 24329972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada.
    Mullen KA; Coyle D; Manuel D; Nguyen HV; Pham B; Pipe AL; Reid RD
    Tob Control; 2015 Sep; 24(5):489-96. PubMed ID: 24935442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.
    Cheung KL; Wijnen BFM; Hiligsmann M; Coyle K; Coyle D; Pokhrel S; de Vries H; Präger M; Evers SMAA
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):87-95. PubMed ID: 29243351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
    Igarashi A; Takuma H; Fukuda T; Tsutani K
    Pharmacoeconomics; 2009; 27(3):247-61. PubMed ID: 19354344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
    Cadier B; Durand-Zaleski I; Thomas D; Chevreul K
    PLoS One; 2016; 11(2):e0148750. PubMed ID: 26909802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
    Atsou K; Chouaid C; Hejblum G
    PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
    Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
    Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
    Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
    Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting.
    Cao P; Smith L; Mandelblatt JS; Jeon J; Taylor KL; Zhao A; Levy DT; Williams RM; Meza R; Jayasekera J
    JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35818125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.